Clare Fisher - 17 Jun 2022 Form 4 Insider Report for Gritstone bio, Inc.

Role
Director
Signature
/s/ Rahsaan Thompson, Attorney-in-Fact for Clare Fisher
Issuer symbol
N/A
Transactions as of
17 Jun 2022
Net transactions value
$0
Form type
4
Filing time
22 Jun 2022, 17:31:18 UTC
Previous filing
04 Jan 2022
Next filing
21 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTS Stock Option (Right to Buy) Award $0 +8,693 $0.000000 8,693 17 Jun 2022 Common Stock 8,693 $2.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date.